Condition or disease | Intervention/treatment | Phase |
---|---|---|
COVID-19SARS CoV 2 Infection | Drug: NVX-CoV2515Drug: NVX-Cov2373Drug: NVX-CoV2373 + NVX-CoV2515Drug: NVX-Cov2540Drug: NVX-CoV2373 + NVX-CoV2540 | Phase 3 |
Condition or disease | Intervention/treatment | Phase |
---|---|---|
COVID-19SARS CoV 2 Infection | Drug: NVX-CoV2515Drug: NVX-Cov2373Drug: NVX-CoV2373 + NVX-CoV2515Drug: NVX-Cov2540Drug: NVX-CoV2373 + NVX-CoV2540 | Phase 3 |